• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

影响 1,2,4-三唑并[1,5-a]嘧啶衍生物与四氢噻吩-1-氧化物或二苯砜配合物稳定性的因素。

Factors Affecting the Stability of Platinum(II) Complexes with 1,2,4-Triazolo[1,5-]pyrimidine Derivatives and Tetrahydrothiophene-1-Oxide or Diphenyl Sulfoxide.

机构信息

Faculty of Chemistry, Nicolaus Copernicus University in Toruń, 7, 87-100 Toruń, Poland.

National Institutes of Medicines, 30/34, 00-725 Warszawa, Poland.

出版信息

Int J Mol Sci. 2022 Mar 26;23(7):3656. doi: 10.3390/ijms23073656.

DOI:10.3390/ijms23073656
PMID:35409016
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8998453/
Abstract

The platinum(II) complexes of general formula [PtCl(dstp)(S-donor)] were dstp 5,7-dimethyl-1,2,4-triazolo[1,5-]-pyrimidine (dmtp), 5,7-ditertbutyl-1,2,4-triazolo[1,5-]pyrimidine (dbtp), 5-methyl-7-isobutyl-1,2,4-triazolo[1,5-]pyrimidine (ibmtp) or 5,7-diphenyl-1,2,4-triazolo[1,5-]pyrimidine (dptp), whereas S-tetrahydrothio-phene-1-oxide (TMSO) or diphenyl sulfoxide (DPSO) were synthesized in a one-pot reaction. Here, we present experimental data (H, C, N, Pt NMR, IR, X-ray) combined with density functional theory (DFT) computations to support and characterize structure-spectra relationships and determine the geometry of dichloride platinum(II) complexes with selected triazolopyrimidines and sulfoxides. Based on the experimental and theoretical data, factors affecting the stability of platinum(II) complexes have been determined.

摘要

标题

新型铂(II)配合物的合成、结构和光谱研究

作者

Marija Glodarić, Vlatka Bugarčić, Marina Grčević, Ivana Tomić, Goran S. Balašević, Ivana Brkljača, Aleksandar R. Despotović

来源出版物

INORGANICA CHIMICA ACTA

卷

407

期

121058

出版年

DEC 2021

页

121058

DOI

10.1016/j.ica.2021.121058

出版国家/地区：UNITED STATES

出版地

NEW YORK

出版商

ACADEMIC PRESS INC ELSEVIER SCIENCE

文献类型

Article

语种

English

ISSN

0020-1693

EISSN

1879-0188

入藏号

WOS:000706624300003

摘要

The platinum(II) complexes of general formula [PtCl(dstp)(S-donor)] were dstp 5,7-dimethyl-1,2,4-triazolo[1,5-]-pyrimidine (dmtp), 5,7-ditertbutyl-1,2,4-triazolo[1,5-]pyrimidine (dbtp), 5-methyl-7-isobutyl-1,2,4-triazolo[1,5-]pyrimidine (ibmtp) or 5,7-diphenyl-1,2,4-triazolo[1,5-]pyrimidine (dptp), whereas S-tetrahydrothio-phene-1-oxide (TMSO) or diphenyl sulfoxide (DPSO) were synthesized in a one-pot reaction. Here, we present experimental data (H, C, N, Pt NMR, IR, X-ray) combined with density functional theory (DFT) computations to support and characterize structure-spectra relationships and determine the geometry of dichloride platinum(II) complexes with selected triazolopyrimidines and sulfoxides. Based on the experimental and theoretical data, factors affecting the stability of platinum(II) complexes have been determined.

关键词

Density functional theory; Platinum(II) complexes; Spectra; Sulfoxides; Triazolopyrimidines

研究领域

化学-无机化学与核化学

DOI 链接：10.1016/j.ica.2021.121058

全文链接

https://www.sciencedirect.com/science/article/pii/S0020169321014449

相似文献

1
Factors Affecting the Stability of Platinum(II) Complexes with 1,2,4-Triazolo[1,5-]pyrimidine Derivatives and Tetrahydrothiophene-1-Oxide or Diphenyl Sulfoxide.影响 1,2,4-三唑并[1,5-a]嘧啶衍生物与四氢噻吩-1-氧化物或二苯砜配合物稳定性的因素。
Int J Mol Sci. 2022 Mar 26;23(7):3656. doi: 10.3390/ijms23073656.
2
Cytotoxic malonate platinum(II) complexes with 1,2,4-triazolo[1,5-a]pyrimidine derivatives: structural characterization and mechanism of the suppression of tumor cell growth.含1,2,4-三唑并[1,5-a]嘧啶衍生物的细胞毒性丙二酸铂(II)配合物：结构表征及抑制肿瘤细胞生长的机制
J Inorg Biochem. 2014 Dec;141:188-197. doi: 10.1016/j.jinorgbio.2014.08.005. Epub 2014 Aug 19.
3
Platinum(II) Complexes with Bulky Disubstitute Triazolopyrimidines as Promising Materials for Anticancer Agents.具有庞大双取代三唑并嘧啶的铂（II）配合物作为有前景的抗癌剂材料
Materials (Basel). 2020 Nov 24;13(23):5312. doi: 10.3390/ma13235312.
4
Nanoencapsulation of a ruthenium(ii) complex with triazolopyrimidine in liposomes as a tool for improving its anticancer activity against melanoma cell lines.脂质体中三唑并嘧啶钌配合物的纳米封装作为提高其对黑素瘤细胞系抗癌活性的工具。
Dalton Trans. 2020 Jan 28;49(4):1207-1219. doi: 10.1039/c9dt03464a. Epub 2020 Jan 6.
5
Multinuclear NMR spectroscopy and antitumor activity of novel platinum(II) complexes with 5,7-disubstituted-1,2,4-triazolo[1,5-a]pyrimidines.新型含5,7-二取代-1,2,4-三唑并[1,5-a]嘧啶的铂（II）配合物的多核核磁共振光谱及抗肿瘤活性
J Inorg Biochem. 2004 Jan;98(1):167-72. doi: 10.1016/j.jinorgbio.2003.09.001.
6
Rational design of dicarboxylato platinum(II) complexes with purine-mimetic ligands as novel anticancer agents.以嘌呤模拟配体为新型抗癌剂的二羧基铂（II）配合物的合理设计。
J Inorg Biochem. 2017 Jul;172:34-45. doi: 10.1016/j.jinorgbio.2017.04.003. Epub 2017 Apr 4.
7
Platinum(II) complexes with 5,7-disubstituted-1,2,4-triazolo [1,5-a]pyrimidines: spectroscopical characterization and cytotoxic activity in vitro.含 5,7-二取代-1,2,4-三唑并[1,5-a]嘧啶的铂(II)配合物：光谱学表征和体外细胞毒性活性。
Spectrochim Acta A Mol Biomol Spectrosc. 2012 Jun;91:126-9. doi: 10.1016/j.saa.2012.01.050. Epub 2012 Jan 30.
8
Mono- and dinuclear platinum(II) compounds with 5,7-dimethyl-1,2,4-triazolo[1,5-a]pyrimidine. Structure, cytotoxic activity and reaction with 5'-GMP.含5,7-二甲基-1,2,4-三唑并[1,5-a]嘧啶的单核和双核铂(II)化合物。结构、细胞毒性活性及与5'-鸟苷酸的反应
Dalton Trans. 2009 Dec 28(48):10736-41. doi: 10.1039/b912404g. Epub 2009 Oct 5.
9
First dinuclear rhodium(II) complexes with triazolopyrimidines and the prospect of their potential biological use.首例双核铑（II）配合物与三唑并嘧啶，并展望其潜在的生物应用。
J Inorg Biochem. 2020 Sep;210:111072. doi: 10.1016/j.jinorgbio.2020.111072. Epub 2020 Mar 23.
10
Synthesis, characterization, crystal structures and in vitro antistaphylococcal activity of organotin(IV) derivatives with 5,7-disubstituted-1,2,4-triazolo[1,5-a]pyrimidine.含 5,7-二取代-1,2,4-三唑并[1,5-a]嘧啶的有机锡(IV)衍生物的合成、表征、晶体结构和体外抗葡萄球菌活性。
J Inorg Biochem. 2012 Jan;106(1):156-63. doi: 10.1016/j.jinorgbio.2011.09.010. Epub 2011 Sep 14.

本文引用的文献

1
Rational design of dicarboxylato platinum(II) complexes with purine-mimetic ligands as novel anticancer agents.以嘌呤模拟配体为新型抗癌剂的二羧基铂（II）配合物的合理设计。
J Inorg Biochem. 2017 Jul;172:34-45. doi: 10.1016/j.jinorgbio.2017.04.003. Epub 2017 Apr 4.
2
SHELXT - integrated space-group and crystal-structure determination.SHELXT——集成空间群与晶体结构测定
Acta Crystallogr A Found Adv. 2015 Jan;71(Pt 1):3-8. doi: 10.1107/S2053273314026370. Epub 2015 Jan 1.
3
Cytotoxic malonate platinum(II) complexes with 1,2,4-triazolo[1,5-a]pyrimidine derivatives: structural characterization and mechanism of the suppression of tumor cell growth.
含1,2,4-三唑并[1,5-a]嘧啶衍生物的细胞毒性丙二酸铂(II)配合物：结构表征及抑制肿瘤细胞生长的机制
J Inorg Biochem. 2014 Dec;141:188-197. doi: 10.1016/j.jinorgbio.2014.08.005. Epub 2014 Aug 19.
4
Synthetic methods for the preparation of platinum anticancer complexes.铂类抗癌配合物的合成方法。
Chem Rev. 2014 Apr 23;114(8):4470-95. doi: 10.1021/cr4004314. Epub 2013 Nov 27.
5
A robust, sensitive, and versatile HMBC experiment for rapid structure elucidation by NMR: IMPACT-HMBC.一种通过 NMR 进行快速结构解析的鲁棒、灵敏、通用的 HMBC 实验：IMPACT-HMBC。
Chem Commun (Camb). 2010 May 21;46(19):3396-8. doi: 10.1039/c000964d. Epub 2010 Apr 1.
6
Energy-consistent pseudopotentials and correlation consistent basis sets for the 5d elements Hf-Pt.用于5d元素铪 - 铂的能量一致赝势和相关一致基组。
J Chem Phys. 2009 Apr 28;130(16):164108. doi: 10.1063/1.3119665.
7
A short history of SHELX.SHELX简史。
Acta Crystallogr A. 2008 Jan;64(Pt 1):112-22. doi: 10.1107/S0108767307043930. Epub 2007 Dec 21.
8
Fast multidimensional NMR by polarization sharing.通过极化共享实现快速多维核磁共振。
Magn Reson Chem. 2007 Jan;45(1):2-4. doi: 10.1002/mrc.1931.
9
Multinuclear NMR spectroscopy and antitumor activity of novel platinum(II) complexes with 5,7-disubstituted-1,2,4-triazolo[1,5-a]pyrimidines.新型含5,7-二取代-1,2,4-三唑并[1,5-a]嘧啶的铂（II）配合物的多核核磁共振光谱及抗肿瘤活性
J Inorg Biochem. 2004 Jan;98(1):167-72. doi: 10.1016/j.jinorgbio.2003.09.001.
10
Cumulative toxicities from cisplatin therapy and current cytoprotective measures.顺铂治疗的累积毒性及当前的细胞保护措施。
Cancer Treat Rev. 1998 Aug;24(4):265-81. doi: 10.1016/s0305-7372(98)90061-5.